Pinned post
Don’t miss this 🧵 on anti-TL1A for #IBD #UC #Crohns!
We review the available data of the 3️⃣ upcoming agents for this 🆕 exciting MOA ! @DCharabaty @vipuljairath 👇🏽👇🏽👇🏽
We review the available data of the 3️⃣ upcoming agents for this 🆕 exciting MOA ! @DCharabaty @vipuljairath 👇🏽👇🏽👇🏽
@MondayNightIBD 1/ #MondayNightIBD #Back2BasicsView quoted post on X
TL1A , a 🆕🎯for inflammation & ?fibrosis
3️⃣anti-TL1A mAbs w/ Ph 2 trials data +active Ph 3 for #UC & #Crohns
⚙️MOA, efficacy, safety
🆓CME 👉🏼mnibd.short.gy/TL1AsTW
Support by an educational grant @Sanofi
📍Where are you in your career?